Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-3,300
Closed -$215K – 7698
2020
Q1
$215K Hold
3,300
– – ﹤0.01% 4667
2019
Q4
$260K Hold
3,300
– – ﹤0.01% 4961
2019
Q3
$263K Buy
+3,300
New +$259K ﹤0.01% 4916
2018
Q2
– Sell
-90,000
Closed -$6.92M – 7758
2018
Q1
$6.92M Buy
+90,000
New +$6.65M 0.01% 1505
2017
Q1
– Sell
-7,000
Closed -$347K – 7361
2016
Q4
$347K Hold
7,000
– – ﹤0.01% 4767
2016
Q3
$367K Buy
+7,000
New +$343K ﹤0.01% 4174
2015
Q1
– Sell
-99,000
Closed -$3.77M – 7468
2014
Q4
$3.77M Hold
99,000
– – ﹤0.01% 1998
2014
Q3
$3.51M Buy
+99,000
New +$3.68M ﹤0.01% 2123

Other funds holding XYL

Citigroup's XYL Position: Q3 2026 in Review

Citigroup reduced its Xylem (XYL) stake by 11% in Q3 2026, selling an estimated $5.62M and leaving 391,128 shares worth $39.6M. The position accounts for 0.01% of the portfolio, ranked #864.

Citigroup first reported a position in XYL in Q2 2013 and has held it in 54 quarters since. The position peaked at $52M in Q2 2026. 1,076 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • Citigroup held 391,128 shares of Xylem worth $39.6M as of Q3 2026.
  • Citigroup sold 49,146 Xylem shares in Q3 2026, an estimated $5.62M.
  • Xylem made up 0.01% of Citigroup's portfolio in Q3 2026, its #864 holding.
  • Citigroup first reported a position in Xylem in Q2 2013 and has held it in 54 quarters since.
  • Citigroup's Xylem position peaked at $52M in Q2 2026.
  • 1,076 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.